Brief: Ars Pharmaceuticals Submits SNDA To FDA For Neffy® 1 Mg Dose For Pediatric Patients With Type I Allergic Reactions Who Weigh 15 To 30 KG (33-66 Lbs.)
09/09/2024 22:31
ARS Pharmaceuticals Inc SPRY.O :
* ARS PHARMACEUTICALS SUBMITS SNDA TO FDA FOR NEFFY® 1 MG
DOSE FOR
PEDIATRIC PATIENTS WITH TYPE I ALLERGIC REACTIONS WHO WEIGH 15
TO 30 KG (33-66 LBS.)
Source text for Eikon: ID:nGNX6tRtv8
Further company coverage: SPRY.O
Recent news on ARS Pharmaceuticals
See all newsARS Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
ARS Pharmaceuticals Q2 neffy revenue rises as epinephrine market share doubles
U.S. STOCKS ON THE MOVE-Bumble, Tempus AI, TD Synnex
U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
ARS Pharma tumbles as allergy nasal spray faces insurance coverage hurdle